K A Gebo

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Patterns of Use and Outcomes in Patients Treated with Etravirine in the HIV Research Network
    Kelly Gebo
    School of Medicine, Johns Hopkins University, 1830 East Monument Street Suite 435, Baltimore, MD 21287, USA
    AIDS Res Treat 2013:492831. 2013
  2. ncbi request reprint Treatment of HIV infection in the older patient
    Kelly A Gebo
    John Hopkins University School of Medicine, Epidemiology, 1830 E Monument Street, Room 442, Baltimore, MD 21205, USA
    Expert Rev Anti Infect Ther 2:733-43. 2004
  3. ncbi request reprint The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 40:169-74. 2005
  4. ncbi request reprint Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 38:96-103. 2005
  5. ncbi request reprint Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 40:609-16. 2005
  6. ncbi request reprint Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 43:426-32. 2006
  7. ncbi request reprint Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection
    Kelly A Gebo
    Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 36:1028-33. 2004
  8. ncbi request reprint HIV and aging: implications for patient management
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Drugs Aging 23:897-913. 2006
  9. ncbi request reprint Hospitalization rates differ by hepatitis C satus in an urban HIV cohort
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Acquir Immune Defic Syndr 34:165-73. 2003
  10. pmc HIV Infection in the Elderly
    Kelly A Gebo
    Johns Hopkins University School of Medicine, 1830 East Monument Street, Room 435, Baltimore, MD 21287, USA
    Curr Infect Dis Rep 11:246-54. 2009

Research Grants

Detail Information

Publications68

  1. pmc Patterns of Use and Outcomes in Patients Treated with Etravirine in the HIV Research Network
    Kelly Gebo
    School of Medicine, Johns Hopkins University, 1830 East Monument Street Suite 435, Baltimore, MD 21287, USA
    AIDS Res Treat 2013:492831. 2013
    ..In a clinical care, nontrial setting, ETR was used in regimens without DRV/r. In this population, the 6-month response rates were similar and durable across all regimens, except when ETR was used without RAL and without a PI...
  2. ncbi request reprint Treatment of HIV infection in the older patient
    Kelly A Gebo
    John Hopkins University School of Medicine, Epidemiology, 1830 E Monument Street, Room 442, Baltimore, MD 21205, USA
    Expert Rev Anti Infect Ther 2:733-43. 2004
    ....
  3. ncbi request reprint The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 40:169-74. 2005
    ....
  4. ncbi request reprint Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 38:96-103. 2005
    ..We examined whether demographic disparities in the use of HAART persist in 2001 and if outpatient care is associated with HAART utilization...
  5. ncbi request reprint Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 40:609-16. 2005
    ..Rapid changes in HIV epidemiology and highly active antiretroviral therapy (HAART) may have resulted in recent changes in patterns of inpatient utilization...
  6. ncbi request reprint Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 43:426-32. 2006
    ..We evaluated the incidence of, risk factors for, clinical presentation, and 1-year outcomes of IE in HIV-infected patients...
  7. ncbi request reprint Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection
    Kelly A Gebo
    Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 36:1028-33. 2004
    ..The absolute CD4 count is the more important measure of immune status and is preferred over the CD4% for making treatment decisions in HIV-infected adults...
  8. ncbi request reprint HIV and aging: implications for patient management
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Drugs Aging 23:897-913. 2006
    ..As the HIV-infected population ages, there is a growing need to better determine the effectiveness of HAART in older patients, and to investigate factors associated with a more rapid course of HIV infection in patients aged >50 years...
  9. ncbi request reprint Hospitalization rates differ by hepatitis C satus in an urban HIV cohort
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Acquir Immune Defic Syndr 34:165-73. 2003
    ..To determine whether hepatitis C virus (HCV) infection status affected hospitalization rates, intensive care utilization rates, and discharge diagnoses between 1995 and 2000 in patients with HIV...
  10. pmc HIV Infection in the Elderly
    Kelly A Gebo
    Johns Hopkins University School of Medicine, 1830 East Monument Street, Room 435, Baltimore, MD 21287, USA
    Curr Infect Dis Rep 11:246-54. 2009
    ..As the HIV-infected population ages, there is a growing need to better determine the ideal HAART regimen and timing of HAART initiation in older patients...
  11. pmc Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Gen Intern Med 18:104-11. 2003
    ..To assess the roles of socioeconomic status, social stability, social stress, health beliefs, and illicit drug use with nonadherence to antiretroviral therapy...
  12. ncbi request reprint Pseudo-outbreak of Mycobacterium fortuitum on a Human Immunodeficiency Virus Ward: transient respiratory tract colonization from a contaminated ice machine
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA
    Clin Infect Dis 35:32-8. 2002
    ..The ice machine was disconnected and cleaned successfully with vinegar and then bleach. Only when a 0.5-micrometer filter was installed were no further patients colonized or water cultures found to be positive...
  13. pmc Prostatic tuberculosis in an HIV infected male
    K A Gebo
    Division of Infectious Diseases, Baltimore, MD 21205, USA
    Sex Transm Infect 78:147-8. 2002
  14. pmc Contemporary costs of HIV healthcare in the HAART era
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    AIDS 24:2705-15. 2010
    ..The delivery of HIV healthcare historically has been expensive. The most recent national data regarding HIV healthcare costs were from 1996-1998. We provide updated estimates of expenditures for HIV management...
  15. ncbi request reprint Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Hepatology 36:S84-92. 2002
    ..In conclusion, screening of patients with chronic hepatitis C with AFP and ultrasound may improve detection of HCC, but studies are needed to determine whether screening improves clinical outcomes...
  16. ncbi request reprint Role of liver biopsy in management of chronic hepatitis C: a systematic review
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Hepatology 36:S161-72. 2002
    ....
  17. ncbi request reprint High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States
    Kelly A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Med Care 43:III23-30. 2005
    ..National data from the mid-1990s demonstrated that many eligible patients with HIV infection do not receive prophylaxis for opportunistic infections (OIs) and that racial and gender disparities existed in OI prophylaxis receipt...
  18. pmc Emergency department utilization among HIV-infected patients in a multisite multistate study
    J S Josephs
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    HIV Med 11:74-84. 2010
    ..The aim of this study was to examine Emergency Department (ED) utilization and clinical and sociodemographic correlates of ED use among HIV-infected patients...
  19. doi request reprint Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy
    B R Yehia
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    HIV Med 12:535-43. 2011
    ..Few data exist on the incidence of and risk factors for bacteraemia across time in the current era of highly active antiretroviral therapy (HAART)...
  20. pmc Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals
    Adena H Greenbaum
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    AIDS 22:2331-9. 2008
    ..Some earlier studies suggest that older patients respond differently to HAART than younger patients. The objective of this study is to compare the effectiveness of HAART in older and younger HIV patients...
  21. pmc A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort
    David J Riedel
    Institute of Human Virology and Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    AIDS Patient Care STDS 22:113-21. 2008
    ..Of note, newer antiretrovirals, particularly atazanavir, lopinivir/ritonavir, tenofovir, abacavir, and efavirenz, were not associated with an increased risk of pancreatitis...
  22. ncbi request reprint Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001
    Marian E Betz
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Med Care 43:III3-14. 2005
    ..An understanding of healthcare utilization patterns is important for optimization of care and resource allocation. We examined the diagnoses for hospitalizations of patients with HIV in 2001...
  23. pmc The impact of illicit drug use and substance abuse treatment on adherence to HAART
    P L Hicks
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    AIDS Care 19:1134-40. 2007
    ..01). Substance abuse treatment interacts with current versus former drug use status to affect adherence to HAART. Substance abuse treatment may improve HAART adherence for former substance users...
  24. ncbi request reprint Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy
    K A Gebo
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument St, Baltimore, MD 21205
    J Acquir Immune Defic Syndr 27:143-52. 2001
    ....
  25. pmc Hospitalization risk following initiation of highly active antiretroviral therapy
    S A Berry
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287 2100, USA
    HIV Med 11:289-98. 2010
    ..The primary objective of this study was to determine hospitalization rates over time in the year after HAART initiation for virological responders and nonresponders...
  26. pmc The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era
    M D Burkey
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    HIV Med 9:858-62. 2008
    ..To define the incidence and risk factors for methicillin resistant Staphylococcus aureus (MRSA) bacteraemia in an HIV-infected population...
  27. ncbi request reprint Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic
    Gregory M Lucas
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    AIDS 16:767-74. 2002
    ..To assess the temporal association of changes in substance abuse with antiretroviral therapy use and adherence, HIV-1 RNA suppression, and CD4 cell count changes in patients attending an urban clinic...
  28. pmc Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use
    Seth Himelhoch
    Division of Services Research, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21212, USA
    Gen Hosp Psychiatry 29:518-25. 2007
    ....
  29. pmc Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions
    PHILIP TODD KORTHUIS
    Department of Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    J Subst Abuse Treat 35:294-303. 2008
    ..These data suggest potential opportunities for improving engagement in substance abuse treatment services...
  30. ncbi request reprint Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS
    J S Josephs
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    HIV Med 8:300-5. 2007
    ..The aim of the study was to assess the prevalence of and factors associated with use of complementary or alternative medicine (CAM) in a multistate, multisite cohort of HIV-infected patients...
  31. pmc Venous thromboembolism in patients with HIV/AIDS: a case-control study
    Aima A Ahonkhai
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 48:310-4. 2008
    ..We investigated the prevalence of established risk factors for VTE in this population and explored novel risk factors...
  32. pmc Neurosyphilis in a clinical cohort of HIV-1-infected patients
    Khalil G Ghanem
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    AIDS 22:1145-51. 2008
    ..To describe the risk factors, clinical presentation, and long-term follow up of patients enrolled in a clinical cohort of HIV-infected patients who were diagnosed and treated for neurosyphilis...
  33. pmc Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients
    Khalil G Ghanem
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Clin Infect Dis 47:258-65. 2008
    ..Our goal was to determine whether the degree of HIV-mediated immunosuppression and the use of highly active antiretroviral therapy impact syphilis serologic responses...
  34. pmc Gonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelines
    Stephen A Berry
    Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287 2100, USA
    Sex Transm Infect 86:481-4. 2010
    ..This study determined GC/CT testing rates in a clinical HIV cohort before and after 2003 when the US Centers for Disease Control and Prevention issued guidelines for GC/CT screening...
  35. pmc Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status
    Richard D Moore
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Clin Infect Dis 47:1102-4. 2008
    ..Among patients with a CD4 cell count <350 cells/mm(3), receipt of HAART was associated with a significantly decreased incidence of comorbidities not related to HIV infection or AIDS...
  36. pmc Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms
    Khalil G Ghanem
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Clin Infect Dis 48:816-21. 2009
    ..The Centers for Disease Control and Prevention recommend certain criteria that warrant lumbar puncture. Here, we assess the performance of these criteria for detecting asymptomatic neurosyphilis (ANS)...
  37. pmc HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use
    Geetanjali Chander
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    AIDS Care 21:655-63. 2009
    ..Co-occurring MI and DU is associated with lower HAART receipt and viral suppression compared to individuals with either MI or DU or neither. Integrating HIV, substance abuse, and mental healthcare may improve outcomes in this population...
  38. pmc Inpatient health services utilization among HIV-infected adult patients in care 2002-2007
    Baligh R Yehia
    Johns Hopkins University School of Medicine, 1830 E Monument St, Room 435, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 53:397-404. 2010
    ..This study examines the frequency of inpatient hospitalization, the number of inpatient days, and factors associated with inpatient utilization in a multistate HIV cohort between 2002 and 2007...
  39. ncbi request reprint Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy
    Gregory M Lucas
    Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Epidemiol 163:412-20. 2006
    ..2, 2.8). Active drug use is temporally linked to HIV disease progression and mortality. Effectively targeting and treating active substance abuse in HIV treatment settings may provide a mechanism to improve clinical outcomes...
  40. ncbi request reprint Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?
    Seth Himelhoch
    Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 37:1457-63. 2004
    ..We investigated whether a current psychiatric disorder (1) affected the time to initiation of HAART, (2) predicted the likelihood of being prescribed HAART for at least 6 months, and (3) affected survival in urban AIDS patients...
  41. ncbi request reprint Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003
    Pennan M Barry
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    AIDS 20:437-44. 2006
    ..To investigate the association between the introduction of HAART and invasive pneumococcal disease (IPD) in HIV-infected patients...
  42. ncbi request reprint An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002
    Richard D Moore
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Acquir Immune Defic Syndr 39:195-8. 2005
    ..This suggests that improved virologic response may also be attributable to other factors such as a greater focus on medication adherence, improved ARV tolerability, and ease of dosing...
  43. pmc Estimating the potential pool of HIV-infected deceased organ donors in the United States
    B J Boyarsky
    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Am J Transplant 11:1209-17. 2011
    ..In the current era of HIV management, a legal ban on the use of these organs seems unwarranted and likely harmful...
  44. pmc Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study
    Seth Himelhoch
    Department of Psychiatry, University of Maryland, Baltimore, MD 21201, USA
    Gen Hosp Psychiatry 31:538-45. 2009
    ....
  45. pmc Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy
    Elena Losina
    Divisions of General Medicine, Department of Medicine, MA 02114, USA
    Clin Infect Dis 49:1570-8. 2009
    ....
  46. pmc Structures of care in the clinics of the HIV Research Network
    Baligh R Yehia
    Johns Hopkins University, Baltimore, Maryland 21287, USA
    AIDS Patient Care STDS 22:1007-13. 2008
    ..Nurse practitioners and physician assistants were highly utilized. These data will facilitate improvements in chronic care management of persons living with HIV...
  47. ncbi request reprint Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India
    Ramona Sobhani
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Indian J Med Res 126:116-21. 2007
    ..The objective of our study was to determine mortality and clinical characteristics of hospitalized HIV-infected individuals in a high HIV prevalence region of India...
  48. pmc Impact of patient race on patient experiences of access and communication in HIV care
    P Todd Korthuis
    Department of Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    J Gen Intern Med 23:2046-52. 2008
    ..Patient-centered care--including the domains of access and communication--is an important determinant of positive clinical outcomes...
  49. pmc HIV patients with psychiatric disorders are less likely to discontinue HAART
    Seth Himelhoch
    Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21212, USA
    AIDS 23:1735-42. 2009
    ..We examined whether having a psychiatric disorder among HIV-infected individuals is associated with differential rates of discontinuation of HAART and whether the number of mental health visits impact these rates...
  50. ncbi request reprint Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians
    Seth Himelhoch
    Division of Services Research, Department of Psychiatry, University of Maryland School of Medicine, 685 West Baltimore St, MSTF Bldg, Suite 300, Baltimore, MD, 21201 1549, USA
    J Prev Interv Community 33:109-20. 2007
    ..10%, p = 0.01). HIV clinicians recognize the importance of recommending HAART treatment to individuals with schizophrenia and AIDS and avoid using antiretroviral medication with known neuropsychiatric side effects...
  51. pmc Late presentation for human immunodeficiency virus care in the United States and Canada
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 50:1512-20. 2010
    ..CONCLUSION. CD4 count at first presentation for HIV care has increased annually over the past 11 years but has remained <350 cells/mm(3), which suggests the urgent need for earlier HIV diagnosis and treatment...
  52. pmc Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
    Stephen J Gange
    NA ACCORD Coordinating Center, Baltimore, MD 21287, USA
    Int J Epidemiol 36:294-301. 2007
  53. pmc Health-related quality of life in HIV-infected patients: the role of substance use
    P Todd Korthuis
    Department of Medicine, Oregon Health and Science University, Portland, Oregon 97239 3098, USA
    AIDS Patient Care STDS 22:859-67. 2008
    ..5 [95% CI -16.4, -4.67]), and inhalants (beta = -14.0 [95% CI -24.1, -3.83]). Facilitating sobriety for patients with attention to specific illicit drugs represents an important avenue for elevating HRQOL in patients living with HIV...
  54. pmc Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals
    Jessica L Long
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    AIDS 22:489-96. 2008
    ..To investigate trends, patient characteristics, and survival associated with AIDS-defining cancer (ADC) and non-AIDS defining cancer (NADC) in the HAART era...
  55. ncbi request reprint Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic
    Anandi N Sheth
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    AIDS Patient Care STDS 20:318-25. 2006
    ..This suggests that if health maintenance screening can be delivered in the same clinic, usage rates are likely to increase...
  56. ncbi request reprint Treatment of chronic hepatitis C: a systematic review
    Geetanjali Chander
    Department of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Hepatology 36:S135-44. 2002
    ..Thus, the combination of peginterferon and ribavirin was the most efficacious treatment in patients with HCV genotype 1. Long-term outcomes were improved in patients with hepatitis C who achieved an SVR with treatment...
  57. ncbi request reprint The epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-haart era among a national managed-care population
    Parthiv J Mahadevia
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    J Acquir Immune Defic Syndr 36:972-7. 2004
    ..05). The incidence of CMV retinitis decreased in this managed-care population during the post-HAART era. Use of oral or intraocular treatment saves costs compared with intravenous treatment in a managed-care environment...
  58. ncbi request reprint The HIV Research Network: a unique opportunity for real time clinical utilization analysis in HIV
    Kelly A Gebo
    Hopkins HIV Rep 15:5-6. 2003
  59. ncbi request reprint Management of hepatitis C: a review of the NIH Consensus Development Conference
    Kelly A Gebo
    Hopkins HIV Rep 14:suppl i-iv. 2002
  60. ncbi request reprint Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001
    Richard M Rutstein
    Division of General Pediatrics, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
    Med Care 43:III31-9. 2005
    ..The aging of the pediatric HIV cohort and advances in antiretroviral therapy for children may have resulted in recent changes in patterns of healthcare utilization...
  61. ncbi request reprint Liver biopsy and screening for cancer in hepatitis C
    Kelly A Gebo
    Am Fam Physician 68:1719, 1723, 1726, 1728. 2003
  62. ncbi request reprint Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002
    John A Fleishman
    Agency for Healthcare Research and Quality, Rockville, Maryland, USA
    Med Care 43:III40-52. 2005
    ..Rapid changes in HIV epidemiology and antiretroviral therapy may have resulted in recent changes in patterns of healthcare utilization...
  63. pmc Associations between outpatient and inpatient service use among persons with HIV infection: a positive or negative relationship?
    John A Fleishman
    Center for Cost and Financing Studies, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850, USA
    Health Serv Res 43:76-95. 2008
    ..To examine the prospective association between frequency of outpatient visits and subsequent inpatient admissions...
  64. ncbi request reprint The lifetime cost of current human immunodeficiency virus care in the United States
    Bruce R Schackman
    Department of Public Health, Weill Medical College of Cornell University, New York, New York 10021, USA
    Med Care 44:990-7. 2006
    ..We sought to project the lifetime cost of medical care for human immunodefiency virus (HIV)-infected adults using current antiretroviral therapy (ART) standards...
  65. ncbi request reprint Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy
    Richard M Rutstein
    Division of General Pediatrics, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    Med Care 43:III15-22. 2005
    ..Limited data are available on the level of virologic suppression and immune function of pediatric patients followed in clinical settings in the HAART era...
  66. ncbi request reprint HIV and hepatitis
    Kelly A Gebo
    Hopkins HIV Rep 15:9-10. 2003
  67. ncbi request reprint Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Hepatitis: glimpses of optimism tempered by sobering mortality statistics
    Kelly A Gebo
    Hopkins HIV Rep 16:8-9. 2004
  68. ncbi request reprint HIV in patients over 50: an increasing problem
    Kelly A Gebo
    Hopkins HIV Rep 16:7-11. 2004

Research Grants3

  1. IMPROVING HEALTH CARE UTILIZATION IN HIV+ DRUG USERS
    Kelly Gebo; Fiscal Year: 2005
    ..Gebo the skills she needs to develop into an independent clinician researcher in HIV epidemiologic and health services research. ..
  2. CLINICAL OUTCOMES IN ELDERLY HIV PATIENTS
    Kelly Gebo; Fiscal Year: 2006
    ..unreadable] [unreadable] [unreadable]..
  3. CLINICAL OUTCOMES IN ELDERLY HIV PATIENTS
    Kelly Gebo; Fiscal Year: 2007
    ..abstract_text> ..